0,803  0,011  Caspase 9 stimulant
0,715  0,006  5 Hydroxytryptamine release stimulant
0,718  0,016  Antineoplastic (lung cancer)
0,662  0,002  LDLR expression enhancer
0,669  0,017  Antineoplastic (colorectal cancer)
0,667  0,016  Antineoplastic (colon cancer)
0,625  0,009  Caspase 3 stimulant
0,554  0,013  CYP2C19 inhibitor
0,542  0,014  Antineoplastic (non-small cell lung cancer)
0,557  0,033  Antineoplastic (solid tumors)
0,524  0,006  Muscle relaxant
0,522  0,007  Tubulin antagonist
0,535  0,020  Antineoplastic (melanoma)
0,539  0,026  Prostate cancer treatment
0,515  0,005  Alpha adrenoreceptor antagonist
0,531  0,023  Vasodilator, peripheral
0,521  0,016  Antineoplastic (multiple myeloma)
0,506  0,004  Topoisomerase I inhibitor
0,499  0,005  DNA intercalator
0,490  0,004  Alpha 2 adrenoreceptor antagonist
0,484  0,005  Dopamine antagonist
0,541  0,062  Apoptosis agonist
0,520  0,049  Antineoplastic (breast cancer)
0,475  0,006  Male reproductive disfunction treatment
0,459  0,005  Erectile dysfunction treatment
0,468  0,020  CYP2D6 inhibitor
0,454  0,008  Topoisomerase II inhibitor
0,476  0,031  Antidepressant
0,449  0,005  5 Hydroxytryptamine 2A antagonist
0,460  0,018  Antineoplastic (lymphoma)
0,458  0,018  Cardiodepressant
0,448  0,009  5 Hydroxytryptamine antagonist
0,473  0,035  Mood disorders treatment
0,441  0,004  Dopamine D1 antagonist
0,443  0,006  Dopamine D2 antagonist
0,468  0,032  Antineoplastic (ovarian cancer)
0,441  0,007  Skeletal muscle relaxant
0,442  0,008  5 Hydroxytryptamine 2 antagonist
0,450  0,017  Antimitotic
0,454  0,022  Vasodilator, coronary
0,442  0,022  Hypoxia-inducible factor 1 alpha inhibitor
0,443  0,029  Antineoplastic (glioma)
0,428  0,018  Sigma receptor agonist
0,432  0,022  DNA damaging
0,418  0,010  Antineoplastic (squamous cell carcinoma)
0,422  0,023  Tumour necrosis factor alpha release inhibitor
0,419  0,025  Antineoplastic (glioblastoma multiforme)
0,399  0,006  5 Hydroxytryptamine 1 antagonist
0,396  0,006  5 Hydroxytryptamine 1A antagonist
0,410  0,022  Antineoplastic (renal cancer)
0,407  0,018  Antineoplastic (small cell lung cancer)
0,409  0,037  Antineoplastic (brain cancer)
0,373  0,008  Alpha 1 adrenoreceptor antagonist
0,424  0,064  5 Hydroxytryptamine release inhibitor
0,364  0,007  Butyrylcholinesterase inhibitor
0,406  0,062  Antileukemic
0,387  0,045  Antipsychotic
0,380  0,040  Antineoplastic (cervical cancer)
0,376  0,039  CYP3A4 inhibitor
0,372  0,038  Cytostatic
0,336  0,005  Dopamine D3 antagonist
0,355  0,024  Cyclic AMP phosphodiesterase inhibitor
0,379  0,049  Anxiolytic
0,338  0,010  Neurotrophic factor enhancer
0,338  0,014  Cholinergic
0,329  0,007  Alpha 2b adrenoreceptor antagonist
0,338  0,017  Antineoplastic (carcinoma)
0,372  0,052  Hepatic disorders treatment
0,330  0,010  Acetylcholinesterase inhibitor
0,366  0,048  Spasmolytic
0,322  0,006  Alpha 2a adrenoreceptor antagonist
0,311  0,009  CDC-like kinase 1 inhibitor
0,354  0,055  Respiratory analeptic
0,311  0,013  Bipolar disorder treatment
0,381  0,085  Histamine release inhibitor
0,302  0,009  Alpha 1a adrenoreceptor antagonist
0,305  0,012  NADPH oxidase inhibitor
0,284  0,007  Alpha 2c adrenoreceptor antagonist
0,278  0,008  5 Hydroxytryptamine 3E antagonist
0,306  0,037  Antihypertriglyceridemic
0,267  0,005  Alpha tubulin antagonist
0,293  0,034  5 Hydroxytryptamine 1E antagonist
0,263  0,004  Antineoplastic alkaloid
0,293  0,035  Sedative
0,300  0,050  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,272  0,024  Tumour necrosis factor antagonist
0,329  0,083  Transcription factor NF kappa B inhibitor
0,284  0,041  Antiparkinsonian, rigidity relieving
0,299  0,059  CYP1A2 inhibitor
0,286  0,048  Antineoplastic (sarcoma)
0,253  0,017  Antiadrenergic
0,247  0,017  Adrenaline antagonist
0,289  0,059  NOS2 expression inhibitor
0,231  0,005  CDC-like kinase 3 inhibitor
0,293  0,069  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,293  0,071  CYP1A2 substrate
0,275  0,054  Antineoplastic (lymphocytic leukemia)
0,279  0,060  Antineoplastic (liver cancer)
0,330  0,112  15-Lipoxygenase inhibitor
0,221  0,004  Phosphodiesterase 11A inhibitor
0,221  0,004  Phosphodiesterase XI inhibitor
0,268  0,052  Amyloid beta aggregation inhibitor
0,255  0,040  P-glycoprotein inhibitor
0,274  0,062  Dyrk kinase inhibitor
0,212  0,005  Phosphodiesterase V inhibitor
0,260  0,055  Psychostimulant
0,216  0,013  Alpha 1b adrenoreceptor antagonist
0,289  0,087  CYP2D6 substrate
0,262  0,063  Vasodilator
0,206  0,007  Beta tubulin antagonist
0,198  0,002  Factor III inhibitor
0,223  0,029  Heat shock protein 90 antagonist
0,220  0,026  Carcinogenic, group 1
0,248  0,056  Clk dual-specificity kinase inhibitor
0,240  0,052  VCAM1 expression inhibitor
0,212  0,024  5 Hydroxytryptamine 2B antagonist
0,199  0,015  Topoisomerase II alpha inhibitor
0,196  0,015  Obsessive-compulsive disorder treatment
0,186  0,007  Phosphodiesterase 5A inhibitor
0,324  0,146  Alzheimer's disease treatment
0,213  0,036  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,207  0,034  Antineoplastic (bone cancer)
0,325  0,155  MAP kinase 1 inhibitor
0,222  0,053  Hepatoprotectant
0,265  0,097  Analeptic
0,202  0,034  Phosphodiesterase inhibitor
0,172  0,008  Acetylcholine M4 receptor antagonist
0,303  0,139  Antiparkinsonian
0,187  0,024  Cyclooxygenase 3 inhibitor
0,236  0,077  DNA synthesis inhibitor
0,166  0,011  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,242  0,087  Antineoplastic (bladder cancer)
0,215  0,061  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,171  0,018  Breast cancer-resistant protein inhibitor
0,161  0,010  5 Hydroxytryptamine 1A agonist
0,212  0,062  Antimigraine
0,232  0,082  Antiprotozoal (Leishmania)
0,218  0,072  Antineoplastic enhancer
0,159  0,013  Alpha 1d adrenoreceptor antagonist
0,188  0,046  Protein kinase stimulant
0,189  0,047  Acetylcholine M1 receptor antagonist
0,240  0,099  Antineoplastic (pancreatic cancer)
0,145  0,005  Topoisomerase II beta inhibitor
0,149  0,009  Alpha 1 adrenoreceptor agonist
0,278  0,138  Antineoplastic (myeloid leukemia)
0,161  0,024  Activin receptor-like kinase 4 inhibitor
0,284  0,151  MAP kinase kinase 6 inhibitor
0,202  0,072  Pneumotoxic
0,196  0,069  CDC-like kinase 4 inhibitor
0,269  0,143  CYP2C9 inhibitor
0,168  0,043  Movement disorders treatment
0,203  0,079  Pyruvate kinase inhibitor
0,141  0,018  Alpha adrenoreceptor agonist
0,245  0,122  Antineoplastic (osteosarcoma)
0,139  0,017  Dopamine agonist
0,185  0,064  Antineoplastic (gastric cancer)
0,236  0,118  12-Lipoxygenase inhibitor
0,221  0,104  UGT1A9 substrate
0,171  0,055  Attention deficit/hyperactivity disorder treatment
0,127  0,014  mTOR complex 2 inhibitor
0,167  0,055  Activin receptor-like kinase 2 inhibitor
0,136  0,024  5 Hydroxytryptamine agonist
0,222  0,111  Antineurogenic pain
0,257  0,147  Antineoplastic (non-Hodgkin's lymphoma)
0,203  0,095  Free radical scavenger
0,244  0,137  CYP3A4 substrate
0,156  0,052  MAP kinase kinase 4 inhibitor
0,108  0,006  5 Hydroxytryptamine 7 agonist
0,106  0,005  Endothelin receptor antagonist
0,183  0,082  CYP2B6 inhibitor
0,173  0,072  Liver fibrosis treatment
0,169  0,069  UGT2B10 substrate
0,130  0,030  Calcium antagonist
0,210  0,110  Cardiotonic
0,108  0,008  Potassium channel (Ca-activated) blocker
0,114  0,014  Phosphodiesterase VI inhibitor
0,128  0,030  Phosphodiesterase IV inhibitor
0,133  0,039  Sphingosine 1-phosphate receptor 2 agonist
0,215  0,121  UGT2B4 substrate
0,195  0,103  Antiamyloidogenic
0,110  0,019  5 Hydroxytryptamine 1 agonist
0,187  0,096  Dependence treatment
0,179  0,089  Abortion inducer
0,100  0,013  Melanin-concentrating hormone receptor 1 antagonist
0,109  0,023  5 Hydroxytryptamine 7 antagonist
0,111  0,026  ATPase (Vacuolar H+) inhibitor
0,166  0,082  Phobic disorders treatment
0,225  0,141  Prostaglandin dehydrogenase inhibitor
0,096  0,013  Glutamate (mGluR7) antagonist
0,151  0,068  Genotoxic
0,130  0,049  Polo-like kinase-4 inhibitor
0,088  0,008  Potassium channel small-conductance Ca-activated blocker
0,122  0,046  Multidrug resistance-associated protein 1 inhibitor
0,204  0,128  Tyrosine 3 hydroxylase inhibitor
0,087  0,011  Dopamine D5 antagonist
0,102  0,026  Dopamine D4 antagonist
0,080  0,008  Alpha 1L adrenoreceptor antagonist
0,076  0,005  Endothelin A receptor antagonist
0,074  0,005  Endothelin B receptor antagonist
0,191  0,121  Antioxidant
0,197  0,128  Proliferative diseases treatment
0,088  0,020  5 Hydroxytryptamine 5A antagonist
0,129  0,061  Papain-like protease (SARS coronavirus) inhibitor
0,190  0,122  Hypoglycemic
0,221  0,153  Antithrombotic
0,076  0,011  Ryanodine receptor antagonist
0,150  0,086  Uterine stimulant
0,077  0,014  5 Hydroxytryptamine 1B agonist
0,077  0,015  Dopamine D2 agonist
0,155  0,093  ATPase inhibitor
0,164  0,102  Antiarrhythmic
0,200  0,140  Radiosensitizer
0,127  0,068  Antineoplastic (uterine cancer)
0,080  0,021  5 Hydroxytryptamine 5 antagonist
0,138  0,080  MAP3K9 inhibitor
0,107  0,049  mTOR complex 1 inhibitor
0,087  0,030  Phosphodiesterase III inhibitor
0,168  0,111  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,223  0,168  Antiprotozoal (Plasmodium)
0,073  0,018  5 Hydroxytryptamine 2 agonist
0,158  0,104  Septic shock treatment
0,093  0,040  Phosphodiesterase 4D inhibitor
0,136  0,083  Pregnane X receptor agonist
0,205  0,153  Ca2+/calmodulin-dependent kinase IV inhibitor
0,123  0,071  Antiviral (Papilloma)
0,097  0,047  5 Hydroxytryptamine 2C antagonist
0,109  0,059  AMP-activated protein kinase stimulant
0,081  0,033  5 Hydroxytryptamine 1B antagonist
0,176  0,129  Cardiovascular analeptic
0,156  0,108  Anesthetic general
0,094  0,047  Tocolytic
0,184  0,137  Radioprotector
0,106  0,060  MAO A inhibitor
0,118  0,072  Acetylcholine antagonist
0,099  0,054  Phosphodiesterase 6D inhibitor
0,119  0,074  DNA repair enzyme inhibitor
0,089  0,044  Glycine receptor antagonist
0,110  0,066  GABA receptor agonist
0,145  0,100  Nitric oxide antagonist
0,141  0,097  Heat shock protein 90 alpha antagonist
0,140  0,096  Melanin inhibitor
0,071  0,027  Heat shock protein 90 beta antagonist
0,125  0,081  Toll-Like receptor 9 antagonist
0,118  0,075  Cholinergic antagonist
0,123  0,081  Sodium channel (voltage-gated) blocker
0,116  0,076  Antiviral (Hepatitis B)
0,114  0,074  Acetylcholine muscarinic antagonist
0,185  0,147  Cardioprotectant
0,115  0,077  MAO inhibitor
0,067  0,029  Phosphodiesterase 4C inhibitor
0,069  0,032  Acetylcholine M5 receptor antagonist
0,165  0,128  VEGF expression inhibitor
0,069  0,032  Alpha 2 adrenoreceptor agonist
0,171  0,135  Antipyretic
0,120  0,084  Sodium channel blocker
0,130  0,095  Chemopreventive
0,104  0,069  DOPA decarboxylase inhibitor
0,109  0,075  Microtubule formation inhibitor
0,064  0,030  Bcl-xL inhibitor
0,044  0,010  Complement C5a chemotactic receptor antagonist
0,052  0,018  Phosphodiesterase 6C inhibitor
0,086  0,053  Inducible nitric-oxide synthase inhibitor
0,078  0,046  Glutamate decarboxylase inhibitor
0,088  0,056  Carcinogenic, group 2A
0,081  0,049  Nicotinic alpha4beta2 receptor antagonist
0,091  0,061  Restless leg syndrome treatment
0,134  0,105  CDC-like kinase 2 inhibitor
0,067  0,039  Acetylcholine M2 receptor antagonist
0,069  0,040  5 Hydroxytryptamine 1D antagonist
0,081  0,053  Acetylcholine nicotinic antagonist
0,121  0,094  Psychosexual dysfunction treatment
0,174  0,146  Antiprotozoal (Trypanosoma)
0,131  0,105  Antinephritic
0,137  0,111  Interleukin 6 antagonist
0,076  0,051  Antitreponemal
0,033  0,009  Follicle-stimulating hormone agonist
0,108  0,085  Antiseptic
0,037  0,017  Melatonin agonist
0,081  0,061  GABA A receptor agonist
0,029  0,009  Dopamine D1 agonist
0,145  0,125  I kappa B kinase epsilon inhibitor
0,076  0,057  Macrophage migration inhibitory factor inhibitor
0,063  0,044  5 Hydroxytryptamine uptake inhibitor
0,057  0,039  5 Hydroxytryptamine 6 antagonist
0,026  0,009  Imidazoline I1 receptor antagonist
0,066  0,049  Neuronal nicotinic receptor antagonist
0,102  0,088  Neutropenia treatment
0,113  0,099  Antifungal enhancer
0,032  0,019  Phosphodiesterase 6B inhibitor
0,113  0,101  Lipid peroxidase inhibitor
0,057  0,045  VEGFR2 expression inhibitor
0,018  0,006  Melatonin receptor 1A antagonist
0,075  0,064  MAP kinase 7 inhibitor
0,130  0,119  Cytotoxic
0,064  0,053  Female sexual dysfunction treatment
0,089  0,079  Nitric-oxide synthase inhibitor
0,038  0,027  Vesicle monoamine transporter inhibitor
0,140  0,132  UGT1A1 substrate
0,041  0,032  Guanylate cyclase inhibitor
0,190  0,182  Antihypertensive
0,207  0,199  TNF expression inhibitor
0,084  0,077  Protein kinase C zeta inhibitor
0,123  0,117  Raynaud's phenomenon treatment
0,058  0,053  5 Hydroxytryptamine 3 agonist
0,091  0,087  Choleretic
0,019  0,015  Antibiotic Quinolone-like
0,087  0,083  Tourette's syndrome treatment
0,030  0,028  Melatonin 1 agonist
0,038  0,036  Plasmepsin II inhibitor
0,022  0,020  Phosphodiesterase 6H inhibitor
0,022  0,020  Phosphodiesterase 6G inhibitor
0,011  0,010  Melatonin 2 antagonist
0,020  0,019  Dopamine autoreceptor agonist

